City of Hope launches AI tool to reduce burden of cancer care

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

City of Hope is using generative artificial intelligence to create operational efficiency, enable AI-driven patient personalization, improve access to clinical trials, and empower breakthrough research.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

With artificial intelligence becoming an increasingly ubiquitous part of the fabric of modern life, Cancer Grand Challenges has committed $10 million to a project aimed at developing AI “co-scientists”—AI agents that could help cancer researchers analyze data, generate hypotheses, and suggest new experiments.
Noetik and Memorial Sloan Kettering Cancer Center have partnered to advance the next generation of cancer biology world models. The collaboration brings together MSK’s depth of oncology expertise and research resources with Noetik’s AI and data foundry capabilities to enable a more diverse and comprehensive model view of cancer development and enhance clinical outcomes.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login